Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 7
Submit an article Journal homepage
1,627
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Targeting the glucagon receptor signaling pathway as a novel strategy to counteract PI3K inhibitor induced hyperglycemia while sustaining tumor PI3K inhibition

Jie Wanga Department of Medicine, Duke Cancer Institute, Durham, NC, USAORCID Iconhttps://orcid.org/0000-0003-2271-5886
ORCID Icon,
Takuya Osadab Department of Surgery, Duke Cancer Institute, Durham, NC, USA
,
Michael A. Morsea Department of Medicine, Duke Cancer Institute, Durham, NC, USA
,
Frank Calzonec ImmPACT-Bio, Camarillo, CA, USA
,
Hai Yand REMD Biotherapeutics, Camarillo, CA, USA
,
Dung Thaid REMD Biotherapeutics, Camarillo, CA, USA
&
H. Kim Lyerlyb Department of Surgery, Duke Cancer Institute, Durham, NC, USACorrespondence[email protected]
 show all
Pages 1761-1764 | Received 24 Aug 2020, Accepted 16 Jan 2021, Published online: 12 Feb 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.